div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentand-immunologydrraghunew-characterized-by-a-primary-or-secondary-deficithtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: and Immunologydr_raghunew · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms The oncogenic potential of multimodality therapy might loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsinreader033viewer20220420055e6fa72496c9e0651d683699html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentand-immunologydrraghunew-characterized-by-a-primary-or-secondary-deficithtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: and Immunologydr_raghunew · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms The oncogenic potential of multimodality therapy might loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsinreader033viewer20220420055e6fa72496c9e0651d683699html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentand-immunologydrraghunew-characterized-by-a-primary-or-secondary-deficithtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: and Immunologydr_raghunew · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms The oncogenic potential of multimodality therapy might loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...